VIROPHARMA $28.80

up +0.11


19/6/2013 04:19 PM  |  NASDAQ : VPHM  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
Get Trend Analysis Icon Get VPHM Trend Analysis - it has outperformed the S&P 500 by 8%

ETF Alternatives



People viewing VPHM also viewed: , , , ,

Competitors

Ticker Name Volume % Change
ACEL TAMIR BIOTECHNOLOGY 5.5K +1.50%
WPHM WINSTON PHARMACEUTICALS 20.0K +1.50%
CKGT CHINA KANGTAI CACTUS BIO 500.0 +1.11%
MLGGY MELDEX INTERNATIONAL 300.0 +1.00%
PARS PHARMOS 3.2K +0.73%
View All

VPHM Stock Analysis

  1.

    ViroPharma Up on Takeover Rumors - Analyst Blog

    (VPHM,SNTS,SLXP,JAZZ )
    As per Reuters, several pharmaceutical companies have shown an interest in acquiring ViroPharma given the company's orphan disease drug portfolio.

  2. Orphan Drug Status for ViroPharma's Maribavir - Analyst Blog

    (VPHM,RHHBY,GSK,SLXP )
    ViroPharma recently received "orphan drug designation" in the EU for its pipeline candidate, maribavir, for the treatment of cytomegaloviral (CMV) in patients suffering from impaired cell mediated immunity.
Free Reports
  1.

    4 Best Buy ETFs for the Current Market

    Don't miss this FREE Special Report from Forbes' fund and ETF expert Jim Lowell.
  2.

    Free Investment Report: 6 Must-Own Emerging Market Stocks

    Gain Valuable Insights into International and Emerging Markets That are Poised for Explosive Growth!
  3.

    Five Chart Patterns You Need to Know!

    Time tested chart patterns for maximum profits. Learn more in this free report from ChartAdvisor.com.
Marketplace
Trading Center